N-terminal and central segments of the type 1 ryanodine receptor mediate its interaction with FK506-binding proteins.

PubWeight™: 0.87‹?›

🔗 View Article (PMC 3668763)

Published in J Biol Chem on April 12, 2013

Authors

Tanya Girgenrath1, Mohana Mahalingam, Bengt Svensson, Florentin R Nitu, Razvan L Cornea, James D Fessenden

Author Affiliations

1: Department of Anesthesia, Perioperative and Pain Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.

Articles cited by this

UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem (2004) 112.47

PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell (2000) 10.25

A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature (1989) 7.02

A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. Nature (1989) 5.53

Ryanodine receptor calcium release channels. Physiol Rev (2002) 5.14

A repeating amino acid motif shared by proteins with diverse cellular roles. Cell (1994) 4.56

Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein. Cell (1994) 4.26

FK506 binding protein associated with the calcium release channel (ryanodine receptor). J Biol Chem (1992) 3.02

Mutations in RYR1 in malignant hyperthermia and central core disease. Hum Mutat (2006) 2.53

Ryanodine receptors: structure, expression, molecular details, and function in calcium release. Cold Spring Harb Perspect Biol (2010) 2.46

Structure of the inositol 1,4,5-trisphosphate receptor binding core in complex with its ligand. Nature (2002) 2.30

Kinetics of FKBP12.6 binding to ryanodine receptors in permeabilized cardiac myocytes and effects on Ca sparks. Circ Res (2010) 2.29

Identification and localization of two triad junctional foot protein isoforms in mature avian fast twitch skeletal muscle. J Biol Chem (1990) 2.11

Cellular functions of immunophilins. Physiol Rev (1996) 1.94

The amino-terminal disease hotspot of ryanodine receptors forms a cytoplasmic vestibule. Nature (2010) 1.79

Coordinated movement of cytoplasmic and transmembrane domains of RyR1 upon gating. PLoS Biol (2009) 1.77

Regulation of calcium release by interdomain interaction within ryanodine receptors. Front Biosci (2002) 1.64

Selective binding of FKBP12.6 by the cardiac ryanodine receptor. J Biol Chem (1996) 1.64

Postulated role of interdomain interaction within the ryanodine receptor in Ca(2+) channel regulation. J Biol Chem (2000) 1.59

Structural and functional conservation of key domains in InsP3 and ryanodine receptors. Nature (2012) 1.42

FKBP12 binds the inositol 1,4,5-trisphosphate receptor at leucine-proline (1400-1401) and anchors calcineurin to this FK506-like domain. J Biol Chem (1997) 1.32

Structural characterization of the RyR1-FKBP12 interaction. J Mol Biol (2005) 1.30

FRET-based mapping of calmodulin bound to the RyR1 Ca2+ release channel. Proc Natl Acad Sci U S A (2009) 1.29

X-ray structures of small ligand-FKBP complexes provide an estimate for hydrophobic interaction energies. J Mol Biol (2000) 1.26

The calcium release channel of sarcoplasmic reticulum is modulated by FK-506 binding protein: effect of FKBP-12 on single channel activity of the skeletal muscle ryanodine receptor. Cell Calcium (1994) 1.24

FKBP12 binding modulates ryanodine receptor channel gating. J Biol Chem (2001) 1.22

Three amino acid residues determine selective binding of FK506-binding protein 12.6 to the cardiac ryanodine receptor. J Biol Chem (1999) 1.19

Central-core disease and malignant hyperpyrexia. Br Med J (1973) 1.17

Cryoelectron microscopy resolves FK506-binding protein sites on the skeletal muscle ryanodine receptor. Biophys J (1996) 1.16

The ryanodine receptor from canine heart sarcoplasmic reticulum is associated with a novel FK-506 binding protein. Biochem Biophys Res Commun (1994) 1.12

Localization of the 12.6-kDa FK506-binding protein (FKBP12.6) binding site to the NH2-terminal domain of the cardiac Ca2+ release channel (ryanodine receptor). J Biol Chem (2002) 1.12

Dynamic, inter-subunit interactions between the N-terminal and central mutation regions of cardiac ryanodine receptor. J Cell Sci (2010) 1.07

Interaction of FKBP12.6 with the cardiac ryanodine receptor C-terminal domain. J Biol Chem (2004) 1.07

Mapping the ryanodine receptor FK506-binding protein subunit using fluorescence resonance energy transfer. J Biol Chem (2010) 1.05

Localization of the dantrolene-binding sequence near the FK506-binding protein-binding site in the three-dimensional structure of the ryanodine receptor. J Biol Chem (2011) 1.05

FRET detection of calmodulin binding to the cardiac RyR2 calcium release channel. Biophys J (2011) 1.00

Förster resonance energy transfer measurements of ryanodine receptor type 1 structure using a novel site-specific labeling method. PLoS One (2009) 0.95

FRET-based localization of fluorescent protein insertions within the ryanodine receptor type 1. PLoS One (2012) 0.91

Positioning of major tryptic fragments in the Ca2+ release channel (ryanodine receptor) resulting from partial digestion of rabbit skeletal muscle sarcoplasmic reticulum. J Biol Chem (1993) 0.90

Central domain of the human cardiac muscle ryanodine receptor does not mediate interaction with FKBP12.6. Cell Biochem Biophys (2005) 0.85

Articles by these authors

Functional role of the "ionic lock"--an interhelical hydrogen-bond network in family A heptahelical receptors. J Mol Biol (2008) 2.47

Kinetics of FKBP12.6 binding to ryanodine receptors in permeabilized cardiac myocytes and effects on Ca sparks. Circ Res (2010) 2.29

Mental health professionals' attitudes towards people with mental illness: do they differ from attitudes held by people with mental illness? Int J Soc Psychiatry (2011) 2.17

Structured patient-clinician communication and 1-year outcome in community mental healthcare: cluster randomised controlled trial. Br J Psychiatry (2007) 2.15

Conformational activation of Ca2+ entry by depolarization of skeletal myotubes. Proc Natl Acad Sci U S A (2004) 1.51

Divergent regulation of ryanodine receptor 2 calcium release channels by arrhythmogenic human calmodulin missense mutants. Circ Res (2014) 1.27

Actin-binding cleft closure in myosin II probed by site-directed spin labeling and pulsed EPR. Proc Natl Acad Sci U S A (2008) 1.26

The therapeutic relationship and adherence to antipsychotic medication in schizophrenia. PLoS One (2012) 1.19

Evidence for conformational coupling between two calcium channels. Proc Natl Acad Sci U S A (2004) 1.18

Defining the molecular components of calcium transport regulation in a reconstituted membrane system. Biochemistry (2003) 1.14

Injection of embryonic stem cells into scarred rabbit vocal folds enhances healing and improves viscoelasticity: short-term results. Laryngoscope (2007) 1.09

Close proximity between residue 30 of phospholamban and cysteine 318 of the cardiac Ca2+ pump revealed by intermolecular thiol cross-linking. J Biol Chem (2002) 1.07

Mapping the ryanodine receptor FK506-binding protein subunit using fluorescence resonance energy transfer. J Biol Chem (2010) 1.05

Functional and physical competition between phospholamban and its mutants provides insight into the molecular mechanism of gene therapy for heart failure. Biochem Biophys Res Commun (2011) 1.03

Interdomain fluorescence resonance energy transfer in SERCA probed by cyan-fluorescent protein fused to the actuator domain. Biochemistry (2008) 1.03

Structural impact of the E113Q counterion mutation on the activation and deactivation pathways of the G protein-coupled receptor rhodopsin. J Mol Biol (2008) 1.02

Cost of treatment of schizophrenia in six European countries. Schizophr Res (2009) 1.01

Quality of life in people with severe mental illness. Reliability and validity of the Manchester Short Assessment of Quality of Life (MANSA). Nord J Psychiatry (2005) 1.01

FRET detection of calmodulin binding to the cardiac RyR2 calcium release channel. Biophys J (2011) 1.00

Cardiac myocyte Z-line calmodulin is mainly RyR2-bound, and reduction is arrhythmogenic and occurs in heart failure. Circ Res (2013) 0.98

Discovery of enzyme modulators via high-throughput time-resolved FRET in living cells. J Biomol Screen (2014) 0.97

Large-scale opening of utrophin's tandem calponin homology (CH) domains upon actin binding by an induced-fit mechanism. Proc Natl Acad Sci U S A (2011) 0.96

Molecular recognition of opioid receptor ligands. AAPS J (2006) 0.95

Characterization of phylogenetically distant members of the adenylate cyclase family from mycobacteria: Rv1647 from Mycobacterium tuberculosis and its orthologue ML1399 from M. leprae. Biochem J (2005) 0.94

Perceived and anticipated discrimination in people with mental illness--an interview study. Nord J Psychiatry (2013) 0.93

Rhodopsin activation switches in a native membrane environment. Photochem Photobiol (2009) 0.92

FRET-based localization of fluorescent protein insertions within the ryanodine receptor type 1. PLoS One (2012) 0.91

Phosphorylated phospholamban stabilizes a compact conformation of the cardiac calcium-ATPase. Biophys J (2013) 0.91

Calmodulin oxidation and methionine to glutamine substitutions reveal methionine residues critical for functional interaction with ryanodine receptor-1. J Biol Chem (2003) 0.90

Elasticity measurements in scarred rabbit vocal folds using air pulse stimulation. Logoped Phoniatr Vocol (2009) 0.90

Mechanisms of shock wave induced endothelial cell injury. Lasers Surg Med (2002) 0.90

Direct detection of calmodulin tuning by ryanodine receptor channel targets using a Ca2+-sensitive acrylodan-labeled calmodulin. Biochemistry (2005) 0.90

Psychometric characteristics of a self-report questionnaire (HPIQ) focusing on health promotion interventions in mental health services. Int J Ment Health Nurs (2008) 0.86

A 2-year follow-up study of people with severe mental illness involved in psychosocial rehabilitation. Nord J Psychiatry (2013) 0.85

In cardiomyocytes, binding of unzipping peptide activates ryanodine receptor 2 and reciprocally inhibits calmodulin binding. Circ Res (2012) 0.84

Non-uniform effectiveness of structured patient-clinician communication in community mental healthcare: an international comparison. Soc Psychiatry Psychiatr Epidemiol (2010) 0.83

Nucleotide activation of the Ca-ATPase. J Biol Chem (2012) 0.82

The ryanodine receptor pore blocker neomycin also inhibits channel activity via a previously undescribed high-affinity Ca(2+) binding site. J Membr Biol (2007) 0.82

Structural determinants of 4-chloro-m-cresol required for activation of ryanodine receptor type 1. Mol Pharmacol (2006) 0.82

Interaction of a G protein-coupled receptor with a G protein-derived peptide induces structural changes in both peptide and receptor: a Fourier-transform infrared study using isotopically labeled peptides. J Mol Biol (2006) 0.81

Psychotropic drugs in nursing- and old-age homes: relationships between needs of care and mental health status. Eur J Clin Pharmacol (2003) 0.80

The attitudes of patients and staff towards aspects of health promotion interventions in mental health services in Sweden. Health Promot Int (2009) 0.79

Individual placement and support - a model to get employed for people with mental illness - the first Swedish report of outcomes. Scand J Caring Sci (2011) 0.78

A novel SERCA inhibitor demonstrates synergy with classic SERCA inhibitors and targets multidrug-resistant AML. Mol Pharm (2013) 0.78

Dimensions and reliability of a questionnaire for the evaluation of subjective experiences of health among patients in mental health services. Issues Ment Health Nurs (2008) 0.78

D1-arginine257 mutants (R257E, K, and Q) of Chlamydomonas reinhardtii have a lowered QB redox potential: analysis of thermoluminescence and fluorescence measurements. Photosynth Res (2008) 0.78

Experiences of stigma among people with severe mental illness. Reliability, acceptability and construct validity of the Swedish versions of two stigma scales measuring devaluation/discrimination and rejection experiences. Nord J Psychiatry (2007) 0.78

Perceived anxiety, depression, and sleeping problems in relation to psychotropic drug use among elderly in assisted-living facilities. Eur J Clin Pharmacol (2005) 0.77

Mapping attitudes and awareness with regard to national guidelines: an e-mail survey among decision makers. J Nurs Manag (2013) 0.77

Functional appliance treatment outcome and need for additional orthodontic treatment with fixed appliance. Swed Dent J (2006) 0.77

Site-specific labeling of the type 1 ryanodine receptor using biarsenical fluorophores targeted to engineered tetracysteine motifs. PLoS One (2013) 0.77

Suicide-nearness assessed with PORT, the Percept-genetic Object-Relation Test: A replication and a reliability study. Bull Menninger Clin (2011) 0.76

'How do we know if this is the best?' Mental health-care professionals' views on national guidelines for psychosocial interventions. Int J Ment Health Nurs (2013) 0.76

Commentary on letter to the editor by Nitasha Sharma. Int J Soc Psychiatry (2013) 0.75

Silicone oil content in ophthalmic viscosurgical devices. J Cataract Refract Surg (2004) 0.75

[The rules for maintenance treatment of opiate dependence are arbitrary and not supported by research]. Lakartidningen (2013) 0.75

Spectrophotometric determination and computational evaluation of the rates of hydrolysis of 9-amino-substituted acridines. J Chem Inf Model (2006) 0.75

Predictors of vocational outcomes using individual placement and support for people with mental illness. Work (2013) 0.75

Differences in self-reported importance of elements of health and subjectively experienced health among outpatients in community mental health services. Arch Psychiatr Nurs (2011) 0.75

Attitudes towards mental illness among health care students at Swedish universities--a follow-up study after completed clinical placement. Nurse Educ Today (2009) 0.75